JNJ·478160104·US·equity·Healthcare - Drug Manufacturers - General-13D/G
JNJ (JOHNSON & JOHNSON) is held by 378 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($52.2B), STATE STREET CORP ($32.6B), JPMORGAN CHASE & CO ($15.3B). Net institutional sentiment: Mixed.
See how JNJ's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer